Back to Rankings

EWTX

Edgewise TherapeuticsC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The May 7, 2026 update kept the two most important clinical milestones intact: Q2 2026 CIRRUS-HCM data and Q4 2026 GRAND CANYON pivotal Becker data. The filing also showed $499.6 million of cash, cash equivalents and marketable securities at March 31, 2026, while the 10-Q says existing liquidity should fund planned operating expenses and capital expenditures for at least the next 12 months [#10-Q-2026-05-07].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -5.4.
What can break
Clinical readouts in HCM or Becker could miss on efficacy, safety, or interpretability, which would pressure a pipeline-led valuation.
Momentum
83
Value
41
Sentiment
44
Setup hits (3d)
— · Net —
AI TargetsBase $40.00 · Bull $50.00 · Bear $24.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net —
Target $49.15
Why
Momentum83 · Δ7d -5.4
Value41 · Δ7d -0.1
Sentiment44 · Δ7d +9.2
So what
Balanced signals. Wait for confirmation before sizing up.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Momentum · See technicals
Momentum
83
26% active weight
Current posture
7d trendFlat
Δ7d
-5.4
Δ21d
-5.3
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
44
34% active weight
Current posture
7d trendImproving
Δ7d
+9.2
Δ21d
+2.2
Why this grade

Composite grade C. Momentum 83.4 / Value 41.1 / Sentiment 44.1

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$4.28B
Beta
0.28
Shares Out
107.59M
P/E (TTM) · Derived
-24.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-28.28
Rev YoY
-
EPS YoY
+6.7%
Gross Margin
-
Op Margin
-
Net Debt
-$526.12M
Current Ratio
22.61
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology